Trademark: 77914543
Word
XIAFLEX COLLAGENASE CLOSTRIDIUM HISTOLYTICUM SUCCESS WITHOUT SURGERY
Status Date
Monday, February 14, 2011
Filing Date
Tuesday, January 19, 2010
Published for Opposition
Tuesday, May 18, 2010
Abandoned Date
Monday, February 14, 2011
5 Pharmaceutical preparations, namely collagenase enzyme used to treat fibroproliferative disease conditions such as Dupuytren's contracture, Peyronie's disease and Frozen Shoulder Syndrome also known as Adhesive Capsulitis
16 Printed educational materials for patients and health care professionals on medical issues
44 Providing online medical information
The color(s) blue, orange and grey is/are claimed as a feature of the mark.
"COLLAGENASE CLOSTRIDIUM HISTOLYTICUM"
The mark consists of the word mark "XIAFLEX" shown in blue with an orange wave design completing the "A" and "F". The words "COLLAGENASE CLOSTRIDIUM HISTOLYTICUM" are shown in grey beneath "XIAFLEX". The words "SUCCESS WITHOUT SURGERY" are shown in orange beneath "COLLAGENASE CLOSTRIDIUM HISTOLYTICUM".
Feb 14, 2011
Abandonment Notice Mailed - No Use Statement Filed
Feb 14, 2011
Abandonment - No Use Statement Filed
Jul 13, 2010
Noa E-Mailed - Sou Required From Applicant
May 18, 2010
Official Gazette Publication Confirmation E-Mailed
May 18, 2010
Published For Opposition
Apr 13, 2010
Law Office Publication Review Completed
Apr 13, 2010
Assigned To Lie
Mar 25, 2010
Approved For Pub - Principal Register
Mar 16, 2010
Teas/Email Correspondence Entered
Mar 16, 2010
Correspondence Received In Law Office
Mar 16, 2010
Teas Response To Office Action Received
Mar 13, 2010
Notification Of Non-Final Action E-Mailed
Mar 13, 2010
Non-Final Action E-Mailed
Mar 13, 2010
Non-Final Action Written
Mar 13, 2010
Assigned To Examiner
Jan 23, 2010
Notice Of Design Search Code Mailed
Jan 22, 2010
New Application Office Supplied Data Entered In Tram
Jan 22, 2010
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
